FP7HORIZONH2020
Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos
- Country
- LTLithuania
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 2,971,503
- Active
- 2009 to 2025
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SGLT2-HYPESGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION (SGLT2-HYPE) | HORIZON | 2025 | Participant | EUR 28,256 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 366,113 |
| SANGUINEEarly detection and screening of hematological malignancies | HORIZON | 2023 | Participant | EUR 487,125 |
| 4.UNCAN.euA Coordination and Support Action to prepare UNCAN.eu platform | HORIZON | 2022 | Participant | EUR 10,000 |
| TRELTwinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania | H2020 | 2021 | Coordinator | EUR 465,903 |
| CARECOMMON ACTION AGAINST HIV/TB/HCV ACROSS THE REGIONS OF EUROPE | H2020 | 2019 | Participant | EUR 90,000 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 133,049 |
| CARREPersonalized patient empowerment and shared decision support for cardiorenal disease and comorbidities | FP7 | 2013 | Participant | EUR 437,680 |
| CULPRIT-SHOCKMultivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock | FP7 | 2013 | Participant | EUR 41,720 |
| AIDPATHAcademia and Industry Collaboration for Digital Pathology | FP7 | 2013 | Participant | EUR 136,633 |
| EUROHYP-1European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke | FP7 | 2012 | Participant | EUR 63,093 |
| NEOMEROEuropean multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis | FP7 | 2010 | Participant | EUR 144,207 |
| TB PAN-NETPan-European network for the study and clinical management of drug resistant tuberculosis | FP7 | 2009 | Participant | EUR 567,725 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.